• Medientyp: E-Artikel
  • Titel: Neqstent coil-assisted flow diverter (NQS) for the treatment of bifurcation aneurysms: the coil-assisted flow diversion safety and performance study (CAFI)
  • Beteiligte: Liebig, Thomas; Gal, Gyula; O′Kelly, Cian; Wodarg, Fritz; Killer-Oberpfalzer, Monika; Ozpeynirci, Yigit; Bester, Maxim; Tsogkas, Ioannis; Psychogios, Marios-Nikos; Jansen, Olav; Fiehler, Jens
  • Erschienen: BMJ, 2023
  • Erschienen in: Journal of NeuroInterventional Surgery
  • Sprache: Englisch
  • DOI: 10.1136/jnis-2022-020056
  • ISSN: 1759-8478; 1759-8486
  • Schlagwörter: Neurology (clinical) ; General Medicine ; Surgery
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:title>Background</jats:title><jats:p>The Neqstent coil-assisted flow diverter (NQS) is a neck bridging device to facilitate coil occlusion of intracranial aneurysms. CAFI is a prospective, single-arm, multicenter study on the safety and performance of the NQS adjunctive therapy device together with platinum coils for treatment of unruptured intracranial aneurysms.</jats:p><jats:sec><jats:title>Methods</jats:title><jats:p>Thirty-eight patients were enrolled. Primary endpoints were occlusion at 6 months for efficacy, and any major stroke or non-accidental death up to 30 days or major disabling stroke within 6 months for safety. Secondary endpoints were re-treatment rate, procedure time, and procedure/device-related adverse events. Procedural and follow-up imaging was reviewed by an independent core laboratory. Adverse events were reviewed and adjudicated by a clinical events committee.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The NQS was successfully implanted in 36/38 aneurysms, 2/38 in the intention-to-treat group did not receive a NQS and were excluded from follow-up after 30 days. In the per protocol group (PP), 33/36 patients were available for angiographic follow-up. Device related adverse events were recorded in 4/38 (10.5%) patients, one hemorrhagic and three thromboembolic. In the PP group, immediate post-treatment adequate occlusion (RR1 and RR2) was seen in 9/36 (25%) and progressed to 28/36 (77.8%) at 6 months. Complete occlusion (RR1) was achieved in 29/36 (80.6%) at the last available angiogram (3/36 were post procedure). The mean procedure time was 129 min (50–300 min, median 120 min).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>The NQS in conjunction with coils appears to be effective in the treatment of intracranial wide-neck bifurcation aneurysms, but its safety remains to be proved in larger series.</jats:p></jats:sec><jats:sec><jats:title>Trial registration number</jats:title><jats:p><jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="clintrialgov" xlink:href="NCT04187573">NCT04187573</jats:ext-link>.</jats:p></jats:sec>